Literature DB >> 10493931

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

J M Leiper1, J Santa Maria, A Chubb, R J MacAllister, I G Charles, G S Whitley, P Vallance.   

Abstract

Methylarginines inhibit nitric oxide synthases (NOS). Cellular concentrations of methylarginines are determined in part by the activity of dimethylarginine dimethylaminohydrolase (DDAH; EC 3.5.3. 18). We have cloned human DDAH and identified and expressed a second novel DDAH isoform (DDAH I and II respectively). DDAH I predominates in tissues that express neuronal NOS. DDAH II predominates in tissues expressing endothelial NOS. These results strengthen the hypothesis that methylarginine concentration is actively regulated and identify molecular targets for the tissue and cell-specific regulation of methylarginine concentration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493931      PMCID: PMC1220543     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  Endogenous inhibitors of nitric oxide synthesis: how important are they?

Authors:  R J MacAllister; P Vallance
Journal:  Exp Nephrol       Date:  1998 May-Jun

2.  Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis.

Authors:  L A Knodler; E O Sekyere; T S Stewart; P J Schofield; M R Edwards
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

3.  Cloning and sequencing of cDNA encoding NG,NG-dimethylarginine dimethylaminohydrolase from rat kidney.

Authors:  M Kimoto; T Sasakawa; H Tsuji; S Miyatake; T Oka; N Nio; T Ogawa
Journal:  Biochim Biophys Acta       Date:  1997-01-04

4.  Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine.

Authors:  Y Kakimoto; S Akazawa
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

5.  Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney.

Authors:  T Ogawa; M Kimoto; K Sasaoka
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

6.  Purification, cDNA cloning and expression of human NG,NG-dimethylarginine dimethylaminohydrolase.

Authors:  M Kimoto; S Miyatake; T Sasagawa; H Yamashita; M Okita; T Oka; T Ogawa; H Tsuji
Journal:  Eur J Biochem       Date:  1998-12-01

7.  Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

Authors:  M Kimoto; H Tsuji; T Ogawa; K Sasaoka
Journal:  Arch Biochem Biophys       Date:  1993-02-01       Impact factor: 4.013

8.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

Authors:  P Vallance; A Leone; A Calver; J Collier; S Moncada
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

9.  Distribution of free methylarginines in rat tissues and in the bovine brain.

Authors:  S Ueno; A Sano; K Kotani; K Kondoh; Y Kakimoto
Journal:  J Neurochem       Date:  1992-12       Impact factor: 5.372

10.  PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation.

Authors:  J Tang; J D Gary; S Clarke; H R Herschman
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

View more
  110 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

Review 2.  Endothelial function and nitric oxide: clinical relevance.

Authors:  P Vallance; N Chan
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

3.  Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia.

Authors:  H Masuda; T Tsujii; T Okuno; K Kihara; M Goto; H Azuma
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.

Authors:  Xinli Hu; Dorothee Atzler; Xin Xu; Ping Zhang; Haipeng Guo; Zhongbing Lu; John Fassett; Edzard Schwedhelm; Rainer H Böger; Robert J Bache; Yingjie Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

5.  Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Authors:  Y-L Tain; C Baylis
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

6.  Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.

Authors:  Yun Wang; Arthur F Monzingo; Shougang Hu; Tera H Schaller; Jon D Robertus; Walter Fast
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

7.  Maternal dietary docosahexaenoic acid supplementation attenuates fetal growth restriction and enhances pulmonary function in a newborn mouse model of perinatal inflammation.

Authors:  Markus Velten; Rodney D Britt; Kathryn M Heyob; Trent E Tipple; Lynette K Rogers
Journal:  J Nutr       Date:  2014-01-22       Impact factor: 4.798

8.  Plasma metabolomic profiles in different stages of CKD.

Authors:  Vallabh O Shah; Raymond R Townsend; Harold I Feldman; Kirk L Pappan; Elizabeth Kensicki; David L Vander Jagt
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

9.  Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.

Authors:  Roman N Rodionov; Daryl J Murry; Sarah F Vaulman; Jeff W Stevens; Steven R Lentz
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Authors:  Sanjana Dayal; Roman N Rodionov; Erland Arning; Teodoro Bottiglieri; Masumi Kimoto; Daryl J Murry; John P Cooke; Frank M Faraci; Steven R Lentz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.